| Literature DB >> 34200147 |
Fátima Brandão1,2,3,4, Carla Costa1,2,3, Maria João Bessa1,2,3,4, Elise Dumortier5, Florence Debacq-Chainiaux5, Roland Hubaux6, Michel Salmon6, Julie Laloy7, Miruna S Stan8, Anca Hermenean8,9, Sami Gharbia8,9, Anca Dinischiotu8, Anne Bannuscher10,11, Bryan Hellack12,13, Andrea Haase10, Sónia Fraga1,2,3, João Paulo Teixeira1,2,3.
Abstract
Several reports on amorphous silica nanomaterial (aSiO2 NM) toxicity have been questioning their safety. Herein, we investigated the in vivo pulmonary toxicity of four variants of aSiO2 NM: SiO2_15_Unmod, SiO2_15_Amino, SiO2_7 and SiO2_40. We focused on alterations in lung DNA and protein integrity, and gene expression following single intratracheal instillation in rats. Additionally, a short-term inhalation study (STIS) was carried out for SiO2_7, using TiO2_NM105 as a benchmark NM. In the instillation study, a significant but slight increase in oxidative DNA damage in rats exposed to the highest instilled dose (0.36 mg/rat) of SiO2_15_Amino was observed in the recovery (R) group. Exposure to SiO2_7 or SiO2_40 markedly increased oxidative DNA lesions in rat lung cells of the exposure (E) group at every tested dose. This damage seems to be repaired, since no changes compared to controls were observed in the R groups. In STIS, a significant increase in DNA strand breaks of the lung cells exposed to 0.5 mg/m3 of SiO2_7 or 50 mg/m3 of TiO2_NM105 was observed in both groups. The detected gene expression changes suggest that oxidative stress and/or inflammation pathways are likely implicated in the induction of (oxidative) DNA damage. Overall, all tested aSiO2 NM were not associated with marked in vivo toxicity following instillation or STIS. The genotoxicity findings for SiO2_7 from instillation and STIS are concordant; however, changes in STIS animals were more permanent/difficult to revert.Entities:
Keywords: DNA damage; gene expression; in vivo inhalation; in vivo instillation; rat lung; silica nanomaterials
Year: 2021 PMID: 34200147 PMCID: PMC8228975 DOI: 10.3390/nano11061502
Source DB: PubMed Journal: Nanomaterials (Basel) ISSN: 2079-4991 Impact factor: 5.076
Figure 1Experimental design of the in vivo studies. (A) Male Wistar rats were exposed by intratracheal installation to different doses (0.09, 0.18, 0.36 mg/animal; n = 4/group) of four aSiO2 NM variants (SiO2_15_Unmod, SiO2_15_Amino, SiO2_40 and SiO2_7) freshly dispersed (Cup-Horn, NanoToxClass SOP) in 50 µL sterile PBS. The control group was intratracheally instilled with the same amount of sterile PBS (Ct; n = 4). The animals were euthanized either 3 days (Exposure group—E) or 21 days (Recovery group—R) after exposure. (B) Male Sprague Dawley rats intraperitoneally (i.p.) injected with methyl methanesulfonate (MMS) at a dose of 100 mg/kg (n = 3), 28 and 4 h before animal euthanasia served as positive controls for the genotoxicity studies. (C) Short-term inhalation studies (STIS) were performed in nulliparous and non-pregnant female Wistar-Han rats (n = 5/group). The animals were exposed (whole-body) during 5 consecutive days for 6 h/day to the aerosolized SiO2_7 (0.5, 2, 5 mg/m3) and TiO2_NM105 (0.5, 2, 10, 50 mg/m3). Control groups (Ct) were exposed to filtered air. The rats were euthanized at 5 days (Exposure group—STIS-E) after the initial exposure or after a recovery period of 21 days (Recovery group—STIS-R).
Comparison of in vivo applied and calculated effective doses of SiO2_7 and TiO2_NM105 in STIS.
| NM | Exposure Conditions | Applied Dose | Effective Dose |
|---|---|---|---|
| SiO2_7 | Exposure group | 0.5 | 0.74 |
| 2 | 2.58 | ||
| 5 | 5.02 | ||
| Recovery group | 0.5 | 0.97 | |
| 2 | 1.41 | ||
| 5 | 5.30 | ||
| TiO2_NM105 | Exposure group | 0.5 | 2.5 |
| 2 | 4.92 | ||
| 10 | 14.98 | ||
| 50 | 41.97 | ||
| Recovery group | 0.5 | 2.47 | |
| 2 | 3.41 | ||
| 10 | 11.57 |
Figure 2Primary (A) and oxidative (B) DNA damage in the rat lung tissue after 3 days (exposure group; E) and 21 days (recovery group; R) of a single intratracheal instillation (0.09–36 mg) of different variants of aSiO2 NM (SiO2_15_Unmod, SiO2_15_Amino, SiO2_7 and SiO2_40), as assessed by the comet assay. Percentage of DNA in the tail (% tail intensity) was used as DNA damage descriptor. Columns represent mean and error bars are the standard deviation (SD); Ct (negative control). * p < 0.05 vs. Ct.
Figure 3Primary (A) and oxidative (B) DNA damage in the rat lung tissue following short-term inhalation exposure (STIS) to aerosolized SiO2 _7 (0.5–5 mg/m3) and TiO2 _NM105 (0.5–50 mg/m3), assessed by the comet assay at 5 days after the initial exposure (exposure group; STIS-E) and after a recovery period of 21 days (recovery group; STIS-R). Percentage of DNA in the tail (% tail intensity) was used as DNA damage descriptor. Columns represent mean and error bars are the standard deviation (SD); Ct (negative control). * p < 0.05 vs. Ct.
Oxidative stress potential scoring based on protein carbonylation.
| Protein Carbonylation | Category | Oxidative Stress Potential |
|---|---|---|
| 100 ± 15 | 1 | None (No) |
| 115–150 | 2 | Low (L) |
| 150–200 | 3 | Medium (M) |
| >200 | 4 | High (H) |
Protein carbonylation (values are fold changes relative to control) in rat lung following NM instillation.
| NM | 0.09 mg | 0.18 mg | 0.36 mg | Overall Category |
|---|---|---|---|---|
| SiO2_15_Unmod_E | 0.80 (No) | 1.30 (L) | 0.71 (No) | L |
| SiO2_15_Amino_E | 1.09 (No) | 0.76 (No) | 1.67 (M) | M |
| SiO2_7_E | 1.03 (No) | 0.51 (No) | 1.30 (L) | L |
| SiO2_40_E | 1.16 (L) | 0.78 (No) | 0.74 (No) | L |
Protein carbonylation (values are fold changes relative to control) in rat lung following NM inhalation.
| NM | 0.5 mg/m3 | 2 mg/m3 | 5 mg/m3 | 10 mg/m3 | 50 mg/m3 | Overall Category |
|---|---|---|---|---|---|---|
| SiO2_7 STIS-E | 0.79 (L) | 1.01 (L) | 1.57 (M) | NA | NA | M |
| TiO2_NM105_STIS-E | 0.68 (L) | 1.04 (L) | NA | 1.41 (M) | 5.53 (H) | H |
Lung gene expression changes shared by rats exposed by instillation to SiO2_15_Unmod and SiO2_15_Amino.
| Gene Symbol | Gene Name | 3 Days_E | |||
|---|---|---|---|---|---|
| SiO2_15_Unmod | SiO2_15_Amino | ||||
| FC | FC | ||||
|
| resistin like alpha | 1.61 × 10−5 | 4.37 | 1.40 × 10−6 | 6.00 |
|
| secreted phosphoprotein 1 | 2.00 × 10−5 | 4.05 | 7.86 × 10−4 | 2.67 |
|
| solute carrier family 26-member 4 | 2.72 × 10−5 | 5.77 | 3.57 × 10−4 | 3.95 |
|
| clavesin 2 | 4.04 × 10−5 | 0.60 | 2.74 × 10−4 | 0.66 |
|
| Z-DNA binding protein 1 | 5.22 × 10−5 | 0.49 | 1.55 × 10−3 | 0.60 |
|
| nuclear protein 1, transcriptional regulator | 1.47 × 10−4 | 1.64 | 1.18 × 10−3 | 1.48 |
|
| growth arrest-specific 2 like 3 | 1.51 × 10−4 | 2.01 | 2.23 × 10−4 | 1.96 |
|
| complement factor I | 1.78 × 10−4 | 2.22 | 8.85 × 10−4 | 1.96 |
|
| epithelial cell transforming 2 | 2.52 × 10−4 | 2.53 | 4.20 × 10−5 | 3.00 |
|
| pyroglutamylated RFamide peptide receptor | 3.43 × 10−4 | 2.39 | 8.19 × 10−4 | 2.21 |
|
| cyclin-dependent kinase 1 | 4.72 × 10−4 | 2.32 | 5.76 × 10−5 | 2.81 |
|
| citrate lyase beta like | 5.64 × 10−4 | 1.90 | 3.12 × 10−5 | 2.33 |
|
| CD177 antigen-like | 5.97 × 10−4 | 2.55 | 1.88 × 10−5 | 3.68 |
|
| lipocalin 2 | 6.94 × 10−4 | 2.32 | 1.71 × 10−4 | 2.64 |
|
| hyaluronan-mediated motility receptor | 8.12 × 10−4 | 2.25 | 1.30 × 10−4 | 2.67 |
|
| F-box protein 5 | 8.13 × 10−4 | 1.81 | 2.49 × 10−4 | 1.96 |
|
| cyclin-dependent kinase inhibitor 3 | 1.07 × 10−3 | 2.36 | 1.85 × 10−4 | 2.82 |
|
| olfactory receptor 196 | 2.04 × 10−3 | 0.69 | 6.58 × 10−4 | 0.66 |
|
| matrix metallopeptidase 12 | 2.09 × 10−3 | 3.65 | 7.07 × 10−4 | 4.36 |
|
| WD repeat domain 35 | 2.09 × 10−3 | 1.59 | 1.46 × 10−3 | 1.62 |
|
| NDC80 kinetochore complex component | 2.15 × 10−3 | 2.19 | 7.57 × 10−4 | 2.42 |
|
| C-X-C motif chemokine ligand 9 | 2.17 × 10−3 | 1.84 | 6.51 × 10−4 | 2.02 |
|
| nucleolar and spindle associated protein 1 | 2.26 × 10−3 | 2.89 | 1.49 × 10−3 | 3.06 |
|
| non-SMC condensin I complex, subunit G | 2.39 × 10−3 | 1.99 | 5.72 × 10−4 | 2.26 |
|
| L-2-hydroxyglutarate dehydrogenase | 3.08 × 10−3 | 1.42 | 6.31 × 10−4 | 1.53 |
|
| centromere protein W | 3.33 × 10−3 | 2.20 | 3.75 × 10−4 | 2.77 |
|
| fatty acid binding protein 5 | 3.45 × 10−3 | 1.43 | 1.56 × 10−4 | 1.66 |
|
|
|
| |||
|
|
| ||||
|
|
|
|
| ||
|
| neuregulin 1 | 2.55 × 10−5 | 2.05 | 1.71 × 10−4 | 2.35 |
|
| olfactomedin-like 3 | 3.81 × 10−4 | 0.66 | 8.39 × 10−6 | 0.43 |
|
| growth arrest specific 8 | 4.69 × 10−4 | 1.47 | 5.29 × 10−5 | 1.96 |
|
| epithelial membrane protein 1 | 6.32 × 10−4 | 0.53 | 1.41 × 10−4 | 0.35 |
|
| collagen, type VI, alpha 1 | 1.13 × 10−3 | 0.69 | 6.35 × 10−5 | 0.49 |
|
| translin-associated factor X interacting protein 1 | 1.76 × 10−3 | 1.62 | 2.92 × 10−5 | 2.82 |
|
| cilia and flagella associated protein 45 | 2.45 × 10−3 | 1.87 | 4.48 × 10−4 | 2.95 |
|
| cellular repressor of E1A-stimulated genes 1 | 2.92 × 10−3 | 1.50 | 1.05 × 10−4 | 2.30 |
|
| synaptotagmin 5 | 3.41 × 10−3 | 1.58 | 1.62 × 10−4 | 2.51 |
|
| polymeric immunoglobulin receptor | 3.94 × 10−3 | 1.48 | 3.09 × 10−4 | 2.12 |
|
| tektin 4 | 3.96 × 10−3 | 1.44 | 6.31 × 10−5 | 2.25 |
Rats were exposed by instillation to 0.36 mg of SiO2_15_Unmod or SiO2_15_Amino and euthanized to isolate total RNA from the lungs either at 3 days (Exposure group; E) and 21 days (Recovery group; R) after initial instillation.
Lung gene expression changes shared by rats exposed by instillation to SiO2_15_Unmod and SiO2_15_Amino.
| Gene Symbol | Gene Name | 3 Days_E | |||
|---|---|---|---|---|---|
| SiO2_15_Unmod | SiO2_15_Amino | ||||
| FC | FC | ||||
|
| resistin like alpha | 1.61 × 10−5 | 4.37 | 1.40 × 10−6 | 6.00 |
|
| secreted phosphoprotein 1 | 2.00 × 10−5 | 4.05 | 7.86 × 10−4 | 2.67 |
|
| solute carrier family 26-member 4 | 2.72 × 10−5 | 5.77 | 3.57 × 10−4 | 3.95 |
|
| clavesin 2 | 4.04 × 10−5 | 0.60 | 2.74 × 10−4 | 0.66 |
|
| Z-DNA binding protein 1 | 5.22 × 10−5 | 0.49 | 1.55 × 10−3 | 0.60 |
|
| nuclear protein 1, transcriptional regulator | 1.47 × 10−4 | 1.64 | 1.18 × 10−3 | 1.48 |
|
| growth arrest-specific 2 like 3 | 1.51 × 10−4 | 2.01 | 2.23 × 10−4 | 1.96 |
|
| complement factor I | 1.78 × 10−4 | 2.22 | 8.85 × 10−4 | 1.96 |
|
| epithelial cell transforming 2 | 2.52 × 10−4 | 2.53 | 4.20 × 10−5 | 3.00 |
|
| pyroglutamylated RFamide peptide receptor | 3.43 × 10−4 | 2.39 | 8.19 × 10−4 | 2.21 |
|
| cyclin-dependent kinase 1 | 4.72 × 10−4 | 2.32 | 5.76 × 10−5 | 2.81 |
|
| citrate lyase beta like | 5.64 × 10−4 | 1.90 | 3.12 × 10−5 | 2.33 |
|
| CD177 antigen-like | 5.97 × 10−4 | 2.55 | 1.88 × 10−5 | 3.68 |
|
| lipocalin 2 | 6.94 × 10−4 | 2.32 | 1.71 × 10−4 | 2.64 |
|
| hyaluronan-mediated motility receptor | 8.12 × 10−4 | 2.25 | 1.30 × 10−4 | 2.67 |
|
| F-box protein 5 | 8.13 × 10−4 | 1.81 | 2.49 × 10−4 | 1.96 |
|
| cyclin-dependent kinase inhibitor 3 | 1.07 × 10−3 | 2.36 | 1.85 × 10−4 | 2.82 |
|
| olfactory receptor 196 | 2.04 × 10−3 | 0.69 | 6.58 × 10−4 | 0.66 |
|
| matrix metallopeptidase 12 | 2.09 × 10−3 | 3.65 | 7.07 × 10−4 | 4.36 |
|
| WD repeat domain 35 | 2.09 × 10−3 | 1.59 | 1.46 × 10−3 | 1.62 |
|
| NDC80 kinetochore complex component | 2.15 × 10−3 | 2.19 | 7.57 × 10−4 | 2.42 |
|
| C-X-C motif chemokine ligand 9 | 2.17 × 10−3 | 1.84 | 6.51 × 10−4 | 2.02 |
|
| nucleolar and spindle associated protein 1 | 2.26 × 10−3 | 2.89 | 1.49 × 10−3 | 3.06 |
|
| non-SMC condensin I complex, subunit G | 2.39 × 10−3 | 1.99 | 5.72 × 10−4 | 2.26 |
|
| L-2-hydroxyglutarate dehydrogenase | 3.08 × 10−3 | 1.42 | 6.31 × 10−4 | 1.53 |
|
| centromere protein W | 3.33 × 10−3 | 2.20 | 3.75 × 10−4 | 2.77 |
|
| fatty acid binding protein 5 | 3.45 × 10−3 | 1.43 | 1.56 × 10−4 | 1.66 |
|
|
|
| |||
|
|
| ||||
|
|
|
|
| ||
|
| neuregulin 1 | 2.55 × 10−5 | 2.05 | 1.71 × 10−4 | 2.35 |
|
| olfactomedin-like 3 | 3.8 × 10−4 | 0.66 | 8.39 × 10−6 | 0.43 |
|
| growth arrest specific 8 | 4.69 × 10−4 | 1.47 | 5.29 × 10−5 | 1.96 |
|
| epithelial membrane protein 1 | 6.32 × 10−4 | 0.53 | 1.41 × 10−4 | 0.35 |
|
| collagen, type VI, alpha 1 | 1.13 × 10−3 | 0.69 | 6.35 × 10−5 | 0.49 |
|
| translin-associated factor X interacting protein 1 | 1.76 × 10−3 | 1.62 | 2.92 × 10−5 | 2.82 |
|
| cilia and flagella associated protein 45 | 2.45 × 10−3 | 1.87 | 4.48 × 10−4 | 2.95 |
|
| cellular repressor of E1A-stimulated genes 1 | 2.92 × 10−3 | 1.50 | 1.05 × 10−4 | 2.30 |
|
| synaptotagmin 5 | 3.41 × 10−3 | 1.58 | 1.62 × 10−4 | 2.51 |
|
| polymeric immunoglobulin receptor | 3.94 × 10−3 | 1.48 | 3.09 × 10−4 | 2.12 |
|
| tektin 4 | 3.96 × 10−3 | 1.44 | 6.31 × 10−5 | 2.25 |
Rats were exposed by instillation to 0.36 mg of SiO2_15_Unmod or SiO2_15_Amino and euthanized to isolate total RNA from the lungs either at 3 days (Exposure group; E) and 21 days (Recovery group; R) after initial instillation.
Gene expression profile identified by TAC analysis following instillation of SiO2_7 or SiO2_40 in rats.
| SiO2_7 | SiO2_40 | ||||
|---|---|---|---|---|---|
| Gene Symbol | NM | 3 Days_E | 21 Days_R | 3 Days_E | 21 Days_R |
|
| NM_012492 | 0.96 ± 0.10 | 1.06 ± 0.22 | 0.78 ± 0.02 | 0.94 ± 0.19 |
|
| NM_012823 | 1.26 ± 0.35 | 0.93 ± 0.08 |
| 0.98 ± 0.08 |
|
| NM_012762 | 1.09 ± 0.11 | 1.04 ± 0.07 | 1.14 ± 0.64 | 1.08 ± 0.17 |
|
| NM_012922 | 1.18 ± 0.16 |
| 1.25 ± 0.27 | 1.17 ± 0.02 |
|
| NM_134360 | 1.00 ± 0.13 | 1.13 ± 0.33 | 0.83 ± 0.07 | 0.75 ± 0.08 |
|
| NM_053353 | 1.56 ± 1.21 | 1.14 ± 0.43 | 1.71 ± 0.52 | 1.32 ± 0.21 |
|
| NM_030845 | 2.99 ± 2.45 | 0.96 ± 0.47 | 3.93 ± 3.10 | 1.38 ± 0.77 |
|
| NM_031509 | 0.86 ± 0.13 |
| 0.67 ± 0.07 | 0.97 ± 0.05 |
|
| NM_012580 |
| 1.31 ± 0.45 | 1.63 ± 0.81 | 1.27 ± 0.35 |
|
| NM_012967 | 1.09 ± 0.23 | 1.09 ± 0.08 |
| 1.05 ± 0.09 |
|
| NM_031512 | 1.12 ± 0.59 | 1.50 ± 0.27 | 1.36 ± 0.08 |
|
|
| NM_013123 | 1.01 ± 0.06 | 1.15 ± 0.09 | 0.90 ± 0.12 | 1.08 ± 0.06 |
|
| NM_013037 | 1.05 ± 0.48 | 1.12 ± 0.37 | 1.31 ± 0.55 |
|
|
| NM_030994 | 1.44 ± 0.34 | 1.11 ± 0.02 | 1.05 ± 0.14 | 1.10 ± 0.08 |
|
| NM_012711 | 1.01 ± 0.22 | 1.10 ± 0.28 | 0.99 ± 0.26 | 1.34 ± 0.39 |
|
| NM_017022 | 1.22 ± 0.48 | 1.09 ± 0.10 | 1.25 ± 0.90 | 1.08 ± 0.05 |
|
| NM_001037780 | 1.59 ± 0.80 | 1.15 ± 0.06 | 1.17 ± 0.40 | 1.36 ± 0.04 |
|
| NM_017347 | 1.13 ± 0.41 | 1.24 ± 0.19 | 0.80 ± 0.08 | 0.97 ± 0.11 |
|
| NM_053829 | 1.60 ± 0.53 | 1.18 ± 0.13 | 0.82 ± 0.10 | 1.00 ± 0.16 |
|
| NM_031020 | 1.20 ± 0.29 | 1.10 ± 0.03 | 0.91 ± 0.09 | 1.01 ± 0.08 |
|
| NM_012611 | 0.73 ± 0.47 | 1.03 ± 0.23 | 1.13 ± 0.75 | 0.28 ± 0.53 |
|
| NM_017000 | 1.16 ± 0.25 | 1.03 ± 0.13 | 1.11 ± 0.38 | 1.01 ± 0.12 |
|
| NM_030870 | 1.12 ± 0.19 | 1.16 ± 0.12 | 1.19 ± 0.10 | 1.10 ± 0.26 |
|
| NM_001113328 | 1.14 ± 0.18 | 1.18 ± 0.07 | 1.09 ± 0.14 | 1.07 ± 0.04 |
|
| NM_001009353 | 1.13 ± 0.32 | 1.13 ± 0.55 | 1.72 ± 0.51 | 1.39 ± 0.11 |
|
| NM_053478 | 1.30 ± 0.22 | 1.37 ± 0.25 | 0.83 ± 0.12 | 1.24 ± 0.13 |
|
| NM_033350 | 1.11 ± 0.02 | 1.08 ± 0.03 | 1.02 ± 0.18 | 1.11 ± 0.14 |
|
| NM_017035 |
| 1.33 ± 0.13 | 0.97 ± 0.18 | 1.26 ± 0.20 |
|
| NM_001077644 | 1.18 ± 0.50 | 1.23 ± 0.16 | 1.00 ± 0.18 | 1.03 ± 0.12 |
|
| NM_031557 | 1.00 ± 0.14 | 1.06 ± 0.11 | 1.20 ± 0.46 | 0.85 ± 0.21 |
|
| NM_017232 | 1.39 ± 0.58 | 0.90 ± 0.37 | 1.76 ± 0.26 | 1.76 ± 1.50 |
|
| NM_022402 | 0.85 ± 0.47 | 1.14 ± 0.08 | 0.50 ± 0.12 | 1.14 ± 0.04 |
|
| NM_017051 | 1.44 ± 0.33 | 0.96 ± 0.19 |
| 1.14 ± 0.24 |
|
| NM_012675 | 0.91 ± 0.57 | 1.14 ± 0.06 | 1.11 ± 0.47 | 1.31 ± 0.58 |
|
| NM_013091 | 1.06 ± 0.24 | 1.07 ± 0.10 | 1.05 ± 0.21 | 0.99 ± 0.03 |
|
| NM_012889 | 0.87 ± 0.23 |
| 1.05 ± 0.13 | 1.20 ± 0.21 |
Rats were exposed by instillation to 0.36 mg of SiO2_7 or SiO2_40 and euthanized to isolate total RNA from the lungs either at 3 days (Exposure group; E) and 21 days (Recovery group; R) after initial instillation. Results obtained from TAC analysis represent the ratio of mRNA abundance as compared with respective control (unexposed) rats, normalized to the expression value of 18s RNA, ACTB, GAPDH, PPIA and calculated based on the comparative Ct (cycle threshold) method (2−ΔΔCt). * p < 0.05 versus control (Student’s t-test).
Gene expression profile identified by TAC analysis following inhalation of SiO2_7 in rats.
| SiO2_7 | |||||||
|---|---|---|---|---|---|---|---|
| STIS-E | STIS-R | ||||||
| Gene Symbol | NM | 0.5 mg/m3 | 2 mg/m3 | 5 mg/m3 | 0.5 mg/m3 | 2 mg/m3 | 5 mg/m3 |
|
| NM_012492 |
|
|
|
|
|
|
|
| NM_012823 | 0.70 ± 0.13 | 0.74 ± 0.10 |
|
|
|
|
|
| NM_012762 | 0.88 ± 0.06 | 0.72 ± 0.10 |
| 1.05 ± 0.47 | 1.09 ± 0.22 | 1.02 ± 0.09 |
|
| NM_012922 | 0.96 ± 0.05 | 1.26 ± 0.22 | 0.83 ± 0.01 | 1.27 ± 0.40 |
| 0.96 ± 0.07 |
|
| NM_134360 | 3.33 ± 4.03 | 0.82 ± 0.37 | 1.04 ± 0.31 | 1.33 ± 0.46 | 1.03 ± 0.17 | 1.00 ± 0.17 |
|
| NM_053353 | 1.21 ± 0.37 |
| 1.05 ± 0.11 | 0.50 ± 0.05 | 0.48 ± 0.06 | 0.57 ± 0.06 |
|
| NM_030845 | 2.34 ± 0.97 | 10.55 ± 8.86 |
| 1.32 ± 0.25 | 1.53 ± 0.56 | 1.99 ± 1.12 |
|
| NM_031509 | 0.47 ± 0.97 | 0.63 ± 0.31 | 0.48 ± 0.03 | 0.77 ± 0.08 | 0.93 ± 0.26 | 0.68 ± 0.14 |
|
| NM_012580 | 0.97 ± 0.20 |
| 1.17 ± 0.05 | 0.86 ± 0.09 | 0.81 ± 0.17 | 0.89 ± 0.24 |
|
| NM_012967 | 1.04 ± 0.15 | 0.93 ± 0.13 | 0.86 ± 0.09 | 1.08 ± 0.08 | 0.93 ± 0.17 | 1.10 ± 0.04 |
|
| NM_031512 |
|
|
| 0.85 ± 0.02 |
| 0.72 ± 0.13 |
|
| NM_013123 | 0.96 ± 0.12 | 0.96 ± 0.13 |
| 0.97 ± 0.08 |
| 0.92 ± 0.07 |
|
| NM_013037 | 0.97 ± 0.28 | 1.19 ± 0.22 |
| 0.94 ± 0.46 | 0.92 ± 0.21 | 0.93 ± 0.16 |
|
| NM_030994 | 1.16 ± 0.09 | 1.44 ± 0.42 | 0.96 ± 0.11 | 1.25 ± 0.16 | 0.84 ± 0.18 | 0.95 ± 0.10 |
|
| NM_012711 | 1.45 ± 0.42 |
|
| 1.01 ± 0.45 | 0.69 ± 0.27 | 1.00 ± 0.02 |
|
| NM_017022 | 0.86 ± 0.15 |
|
|
| 0.75 ± 0.16 | 0.81 ± 0.34 |
|
| NM_001037780 | 0.90 ± 0.09 | 1.01 ± 0.19 | 0.83 ± 0.10 | 0.87 ± 0.07 |
| 1.00 ± 0.11 |
|
| NM_017347 | 0.90 ± 0.18 | 0.90 ± 0.12 | 0.85 ± 0.14 | 0.96 ± 0.29 | 0.85 ± 0.36 | 0.93 ±0.25 |
|
| NM_053829 | 0.74 ± 0.23 | 0.98 ± 0.23 | 0.73 ± 0.07 | 0.87 ± 0.10 | 0.91 ± 0.33 | 1.33 ± 0.41 |
|
| NM_031020 | 0.98 ± 0.09 | 1.01 ± 0.10 |
| 1.08 ± 0.18 | 0.88 ± 0.08 | 0.96 ± 0.02 |
|
| NM_012611 |
|
|
| 1.92 ± 2.45 | 0.46 ± 0.34 | 1.41 ± 1.39 |
|
| NM_017000 |
| 0.96 ± 0.31 |
| 1.31 ± 0.38 | 0.94 ± 0.22 | 1.10 ± 0.07 |
|
| NM_030870 | 0.79 ± 0.10 | 0.92 ± 0.18 | 0.59 ± 0.07 | 0.82 ± 0.10 | 0.93 ± 0.26 | 0.81 ± 0.07 |
|
| NM_001113328 | 0.91 ± 0.27 | 1.04 ± 0.06 |
| 1.02 ± 0.20 | 0.91 ± 0.21 | 1.03 ± 0.14 |
|
| NM_001009353 | 1.09 ± 0.23 |
| 0.92 ± 0.24 | 0.77 ± 0.10 |
| 0.83 ± 0.28 |
|
| NM_053478 |
| 1.31 ± 0.32 |
| 1.04 ± 0.18 | 0.79 ± 0.14 | 0.99 ± 0.32 |
|
| NM_033350 | 1.05 ± 0.16 |
|
| 0.99 ± 0.12 |
|
|
|
| NM_017035 | 0.97 ± 0.20 | 1.09 ± 0.28 |
| 0.68 ± 0.06 |
|
|
|
| NM_001077644 | 0.84 ± 0.15 | 0.99 ± 0.26 | 0.70 ± 0.17 | 1.12 ± 0.12 | 0.89 ± 0.07 | 1.07 ± 0.35 |
|
| NM_031557 | 0.83 ± 0.16 | 1.08 ± 0.29 | 0.68 ± 0.09 * | 1.11 ± 0.23 | 1.00 ± 0.10 | 0.76 ± 0.05 |
|
| NM_017232 | 0.96 ± 0.30 |
| 0.89 ± 0.39 | 1.55 ± 0.54 | 0.94 ± 0.59 | 0.77 ± 0.23 |
|
| NM_022402 | 0.98 ± 0.02 | 1.57 ± 1.00 | 0.92 ± 0.06 | 1.39 ± 0.29 | 0.91 ± 0.18 | 0.96 ± 0.07 |
|
| NM_017051 | 1.19 ± 0.15 |
|
| 1.31 ± 0.68 | 1.11 ± 0.22 | 1.09 ± 0.11 |
|
| NM_012675 |
|
|
| 1.41 ± 0.34 | 1.28 ± 0.22 | 1.38 ± 0.53 |
|
| NM_013091 | 0.90 ± 0.04 | 0.97 ± 0.21 | 0.80 ± 0.11 | 1.04 ± 0.13 | 0.85 ± 0.17 | 0.97 ± 0.06 |
|
| NM_012889 | 0.95 ± 0.17 | 1.15 ± 0.10 | 1.07 ± 0.24 | 1.22 ± 0.11 | 1.32 ± 0.46 | 1.10 ± 0.24 |
Rats were exposed by inhalation to three doses of SiO2_7 (0.5, 2 or 5 mg/m3), and rats were euthanized to isolate total RNA from the lungs directly after exposure (5 days, STIS-E) or after a recovery period of 21 days (STIS-R). Results obtained from TAC analysis represent the ratio of mRNA abundance as compared with respective control (unexposed) rats, normalized to the expression value of 18s RNA, ACTB, GAPDH, PPIA genes and calculated based on the comparative Ct (cycle threshold) method (2−ΔΔCt). * p < 0.05 versus control (Student’s t-test).